In addition, analysis of the GEO database for breast cancer patients showed a positive correlation between GPR110 expression and CD44 gene and a negative correlation between GPR110 expression and CD24 gene (Fig. 3G). This evidence concerns the gene ADGRF1 and breast carcinoma.